Purchase Order 7571TE26P00067

FDA awarded a purchase order to Lhasa LIMITED for $131,835 on May 21, 2025, exercising option year 1 under the Lhasa Knowledge Suite Nexus agreement covering Derek, Meteor, Vitic, Sarah, and Zeneth software platforms. Performance occurs in Silver Spring, Maryland, with final completion by May 28, 2029. The order is firm fixed price with no set-aside and procures software subscriptions and licensing for chemical safety, toxicity assessment, environmental fate analysis, and regulatory risk...

The U.S. Food and Drug Administration (FDA) awarded a $83,981 firm-fixed-price purchase order contract to Lhasa LIMITED, a non-profit organization based in the United Kingdom. The contract is for the provision of Lhasa's suite of software tools, including Derek Nexus, Meteor Nexus, VITIC Nexus, Sarah Nexus, and Zeneth. These predictive toxicology and metabolism software products support the FDA's research and regulatory activities related to chemical safety and environmental protection. The...

<p>The Food and Drug Administration awarded a purchase order to Simulations Plus Inc. for ADMET Predictor software valued at $68,212.96, with an award date of August 7, 2026 and ultimate completion on August 6, 2031. The software is a computational platform using artificial intelligence and machine learning for the FDA's Office of Cosmetics and Colors. Place of performance is Silver Spring, Maryland. The purchase order is firm fixed price with no set-aside designation.</p>

The Food and Drug Administration awarded a purchase order to Siemens Government Technologies Inc. for a gPROMS lyophilization modeling toolbox license on July 12, 2026, with a ceiling value of $35,449.44. The order covers one single-user license with a 12-month subscription, including nonlinear predictive control software optimized for high-performance computing to model time-dependent lyophilization cycles using first-principles equations. The platform incorporates an operational intelligence...

The Food and Drug Administration (FDA) awarded a $127,000 firm fixed-price purchase order to Creme Software LTD for the development of a Cosmetic Product Consumer Use Database and Safety Assessment Software. The contract, awarded on February 13, 2026, with performance in Silver Spring, Maryland, will be completed by February 15, 2031. This award includes no small business set-aside and represents Creme Software's continued partnership with the FDA on consumer safety initiatives. Creme Software...

<p>The Food and Drug Administration issued a purchase order to Skylight Inc. valued at $4,281,769.26 on July 6, 2025, for complaint submission experience minimum viable product development. Performance will occur in Silver Spring, Maryland, with an ultimate completion date of January 6, 2027. The order carries firm fixed price terms and no small business set-aside.</p>

The Food and Drug Administration awarded a purchase order to Anylogic North America, LLC for $119,895.92 to exercise option four providing AnyLogic software licenses and maintenance from August 17, 2026 through August 16, 2027. No set-aside applies. Performance occurs at Silver Spring, Maryland. The order covers simulation modeling software licensing and maintenance to support the Centers for Devices and Radiological Health's computational modeling and business process simulation requirements....

<p>The Food and Drug Administration awarded a purchase order to Chemical Computing Group ULC for Molecular Operating Environment software licensing, with a ceiling value of $163,600.00 and an award date of June 29, 2026. Place of performance is Silver Spring, Maryland. The ultimate completion date is June 28, 2031. This is a firm fixed-price purchase order with no set-aside applied.</p>

<p>The Food and Drug Administration awarded a purchase order to Siemens Industry Software Inc. for an integration platform of process analytical technology systems and digital twin technology for lyophilization, valued at $199,779.12, with an award date of September 30, 2025. Performance will be completed by September 29, 2026 and will take place in Silver Spring, Maryland. The order carries firm fixed-price pricing and no set-aside designation.</p>

The Food and Drug Administration issued a delivery order to Mpf-Zai Solutions LLC, a woman-owned small business, on September 15, 2023, under the Competitive 8(a) set-aside, with a ceiling value of $770,282.37 for cosmetic registration and product listing data management support services. Ultimate completion date is September 14, 2025. Place of performance is Silver Spring, MD. The order is firm fixed price. SCI reporting shows FY2024 invoicing of $382 thousand across 2.3 FTEs and 4,846...